This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing ...

Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...

The alliance is expected to propel Headlands’ ongoing expansion, with a focus on enhancing its centralised infrastructure.

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Takeda Pharmaceuticals plans to launch innovative drugs in India. The company will explore India's clinical trial ecosystem.

Experts say there is scope for improvement in clinical trial numbers, photo Le Toan Ho Chi Minh City Oncology Hospital is seeking opportunities to join clinical trials to help patients gain access to ...